Mats Walder
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 24
-
- Antimicrobial Resistance in Staphylococcus 9
- Viral gastroenteritis research and epidemiology 6
- Co-authors
- Arne Forsgren (15 shared papers)Inga Odenholt (9 shared papers)Jan Ursing (5 shared papers)Marlene Wullt (4 shared papers)Eva Melander (7 shared papers)Karin Sandstedt (3 shared papers)Johan Tham (6 shared papers)S Cronberg (5 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Antimicrobial Chemotherapy (5 papers)Infection Control and Hospital Epidemiology (4 papers)Current Microbiology (3 papers)
- Partner nations
- SwedenSwitzerlandUnited Kingdom
In The Last Decade
Mats Walder
83 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 119
- Molecular Medicine 570
- Applied Microbiology and Biotechnology 139
- Endocrinology 232
- Clinical Biochemistry 236
- Infectious Diseases 560
Countries citing papers authored by Mats Walder
This map shows the geographic impact of Mats Walder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Walder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Walder more than expected).
Fields of papers citing papers by Mats Walder
This network shows the impact of papers produced by Mats Walder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Walder. The network helps show where Mats Walder may publish in the future.
Co-authors
The 25 scholars most cited alongside Mats Walder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 132 | |
| 2 | Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. | 1997 | 115 |
| 3 | 1983 | 97 | |
| 4 | 2010 | 90 | |
| 5 | 1990 | 89 | |
| 6 | 2010 | 74 | |
| 7 | 2003 | 65 | |
| 8 | 2006 | 62 | |
| 9 | 1979 | 54 | |
| 10 | 2011 | 46 | |
| 11 | 2011 | 43 | |
| 12 | 1994 | 41 | |
| 13 | 2006 | 40 | |
| 14 | 2012 | 39 | |
| 15 | 1988 | 38 | |
| 16 | 1985 | 37 | |
| 17 | 1982 | 37 | |
| 18 | 1998 | 36 | |
| 19 | 1989 | 36 | |
| 20 | 1981 | 34 |
About Mats Walder
Mats Walder is a scholar working on Molecular Medicine, Infectious Diseases, Pharmacology, Epidemiology and Clinical Biochemistry, having authored 83 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers), Bacterial Identification and Susceptibility Testing (11 papers), Salmonella and Campylobacter epidemiology (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Pneumonia and Respiratory Infections (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Streptococcal Infections and Treatments (5 papers). The work is most often cited by research in Molecular Medicine (570 citations), Applied Microbiology and Biotechnology (139 citations), Endocrinology (232 citations), Clinical Biochemistry (236 citations) and Infectious Diseases (560 citations). Mats Walder has collaborated with scholars based in Sweden, Switzerland and United Kingdom. Frequent co-authors include Arne Forsgren, Inga Odenholt, Jan Ursing, Marlene Wullt, Eva Melander, Karin Sandstedt, Johan Tham, S Cronberg, Lennart Sanzén and J. Renneberg. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Infection Control and Hospital Epidemiology and Current Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.